SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-123577
Filing Date
2020-11-10
Accepted
2020-11-10 16:05:40
Documents
14
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035567d1_8k.htm   iXBRL 8-K 27224
2 EXHIBIT 99.1 tm2035567d1_ex99-1.htm EX-99.1 62384
6 GRAPHIC tm2035567d1_ex99-1img001.jpg GRAPHIC 13380
  Complete submission text file 0001104659-20-123577.txt   297146

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20201109.xsd EX-101.SCH 3201
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20201109_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20201109_pre.xml EX-101.PRE 22720
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2035567d1_8k_htm.xml XML 3745
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 201301112
SIC: 2834 Pharmaceutical Preparations